Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...

It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...

Ministers have been urged to ditch "gimmicks and soundbites" while addressing the soaring cost of obesity to the NHS.

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

With new weight-loss drugs hailed as ‘miracle’ medicines, Harriet Symonds explores whether their increasing popularity should ...

Weight-loss drugs Ozempic and Wegovy have become popular worldwide. Many people have also reported suffering some serious ...

Even when patients are aware of the risks, adherence to diet, exercise, and medication remains low—even among those who have ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

The current pain caused by the high cost of the GLP-1 agonist anti-obesity drugs will pass. Prachi Patkee and other analysts ...